Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al
| Mylan Pharmaceuticals Inc. |
| Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc. |
| 1:2023cv00556 |
| May 19, 2023 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 15, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney Ty W. Callahan, Ty W. Callahan, Tung-On Kong, Elham F. Steiner, and Wendy L. Devine for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Filing 16 MOTION for Pro Hac Vice Appearance of Attorney T.O. Kong, Wendy L. Devine, Elham Firouzi Steiner and Ty W. Callahan of Wilson Sonsini Goodrich & Rosati P.C. - filed by Mylan Pharmaceuticals Inc.. (Palapura, Bindu) |
SO ORDERED, re #16 MOTION for Pro Hac Vice Appearance of Attorney T.O. Kong, Wendy L. Devine, Elham Firouzi Steiner and Ty W. Callahan of Wilson Sonsini Goodrich & Rosati P.C., filed by Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 6/14/2023. (nms)
|
|
SO ORDERED, re #13 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Janssen Pharmaceuticals, Inc. answer due 8/21/2023). Signed by Judge Richard G. Andrews on 6/7/2023. (nms)
|
| Filing 15 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Filing 14 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH; Corporate Parent no parent corporation for Bayer AG filed by Bayer AG, Bayer Intellectual Property GMBH. (Fahnestock, Derek) |
| Filing 13 STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/7/2023 (nms). |
| Filing 12 WAIVER OF SERVICE returned executed by Mylan Pharmaceuticals Inc.: For Bayer AG waiver sent on 5/23/2023, answer due 8/21/2023. (Moore, David) |
| Filing 11 WAIVER OF SERVICE returned executed by Mylan Pharmaceuticals Inc.: For Bayer Intellectual Property GMBH waiver sent on 5/23/2023, answer due 8/21/2023. (Moore, David) |
| Filing 10 WAIVER OF SERVICE returned executed by Mylan Pharmaceuticals Inc.: For Janssen Pharmaceuticals, Inc. waiver sent on 5/23/2023, answer due 7/24/2023. (Moore, David) |
| Remark: The Court has reviewed Plaintiff's letter dated May 25, 2023 (D.I. #9 ), and agrees with it. The MDL office was notified on May 26, 2023, that this case should not be considered a member case to MDL. 21-3017-RGA.(nms) |
| Filing 9 Letter to Clerk of Court, from David E. Moore, regarding the remark entered on the docket regarding MDL affiliation. (Moore, David) Modified on 5/25/2023 (nms). |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:23-cv-00551-RGA, 1:23-cv-00556-RGA (rjb) |
| Filing 8 [SEALED] EXHIBIT B to #2 Complaint, by Mylan Pharmaceuticals Inc.. (nms) |
|
Filing 7
ORAL ORDER: The Motion for Leave to File Complaint and Exhibit B Under Seal (D.I. #1 ) is GRANTED in part and DENIED in part. The request to seal the complaint is DENIED and the request to file Exhibit B under seal is GRANTED. Ordered by Judge Richard G. Andrews on 5/22/2023. (nms)
|
| Remark: Exit electronic copies to Duty Judge RGA. (jdb) |
| Remark: Case submitted for routine judicial assignment. MDL Panel notified. (jdb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent's Mylan Inc. and Viatris Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc. (jdb) |
| Filing 5 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,415,053 B2. (jdb) |
| Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/14/2018. Date of Expiration of Patent: 11/13/2024. (jdb) |
| Filing 3 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jdb) |
| Filing 2 COMPLAINT for Patent Infringement filed against Bayer AG, Bayer Intellectual Property GMBH, and Janssen Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4140782) - filed by Mylan Pharmaceuticals Inc.. (Attachments: #1 Exhibit A, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Civil Cover Sheet)(jdb) Modified on 5/22/2023 (nms). |
| Filing 1 MOTION for Leave to File Complaint and Exhibit B Under Seal - filed by Mylan Pharmaceuticals Inc. (Attachments: #1 Text of Proposed Order)(jdb) |
| No Summons Issued. (jdb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
